The DIVE/DPV registries: evolution of empagliflozin use in clinical practice in Germany

Autor: Johannes Foersch, Dirk Raddatz, Christian Wagner, Carsten Spies, Rosmarie Weber-Lauffer, Kerstin König, Sascha R. Tittel, Diether Erath, Jost Hilgenberg, Jochen Seufert, Ludwin Ley, Maximilian Gabler, Peter Bramlage, Thomas Danne

Publikováno v: BMJ Open Diabetes Research & Care
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)

IntroductionEmpagliflozin reduced morbidity and mortality in patients with type 2 diabetes mellitus (T2DM) in clinical trials. A registry study was undertaken to describe evolution of patient characteristics and assess the real-world effectiveness/sa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55e18ab9f653526b7b3583cbc826bee5
https://doi.org/10.1136/bmjdrc-2020-001486

Impact of Empagliflozin on Blood Pressure in Patients with Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication

Autor: Christopher P. Cannon, Ilkka Tikkanen, Uli Christian Broedl, Odd-Erik Johansen, Hans J. Woerle, Giuseppe Mancia, Ludwin Ley, Cordula Zeller

In the EMPA-REG BP trial, empagliflozin 10 mg and 25 mg once daily reduced glycohemoglobin, blood pressure (BP), and weight versus placebo in patients with type 2 diabetes mellitus and hypertension. Patients received placebo (n=271), empagliflozin 10

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e747a39b4b9a227928f07634f1edb68
http://hdl.handle.net/10281/200013

Single-Pill Combination of Telmisartan/Amlodipine in Patients With Severe Hypertension: Results From the TEAMSTA Severe HTN Study

Autor: F. Barucq, B. Minescu, S. Slabic, A. Ivleva, Y. Svyshchenko, Catalina Arsenescu Georgescu, R. Marple, N. Gotcheva, A. Patron, F. Robin, P. Touzet, T. Lívia, K. Crump, H. A. Punzi, M. Pouget, I. Vykhovanyuk, D. Lecaignard, J. Y. Yang, O. Korzh, J. M. Hill, A. Vishnevsky, B. D. Forestier, V. Shatilo, L. Kononenko, E. Hannoush, A. MacAgno, B. Gil-Extremera, G. P. Tatu-Chitoiu, J. L. Diaz, B. Perrin, E. Jordan, P. J. Lane, R. Combet, C. Fivel, D. Taminau, I. Karen, R. Struble, P. Causse, M. Ripoll, L. Yena, M. Bismuth, C. Giraldi, D. Raev, A. Faynyk, I. Horný, M. Bourgoin, L. Jagminas, I. Manitiu, I. Gordeev, O. Jerábek, V. Mincheva, J. P. Jacquet, N. Breton, M. Cristea, P. Chalaux, L. Levinson, Joel M. Neutel, T. Tyurina, C. A. Percheron, Ludwin Ley, B. Lemarie, J. Oliván, S. Milanov, V. András, A. Khennouf, D. Gaita, A. Martynov, S. Hojerová, L. Jappy, B. Geoffray, D. G. Cheung, R. D. Eyzaguirre, J. C. Deme, M. Depoisier, Richard Vinisko, N. Gabriella, G. Martocq, C. J. Mello, V. Kolíková, R. E. Tidman, J. Gonsorcík, B. Goloborodko, Y. Sirenko, N. R. Patel, N. Zlatareva, P. Cayron, M. H. Kim, A. Filippov, P. Záreczky, M. Hranai, J. Nagel, Björn Dahlöf, G. Venturini, B. Dimon, M. Y. Lee, M. H. Vuong, Z. Károly, C. G. Park, N. Bittar, S. M. Kang, S. H. Baek, B. Michalak, G. Pencheva, A. M. Salajan, M. Flosi, J. C. Kuchar, Henry R. Black, I. Benedek, B. Zehnder, I. László, R. J. Graf, G. Aroutiounov, D. Sacareau, O. Geronimi, S. Dragulescu, P. Michellier, P. Ibolya, V. Zadionchenko, Z. Krumlov Lorenc, S. Petranov, A. Chaleon, T. Donova, Holly Defeo, M. Peterka, D. E. Webster, D. R. Ricci, D. B. Jack, R. L. Eddy, J. J. Roger, M. B. Samson, R. Judit, A. Chalvignac, J. L. Tovar, J. L. Pool, E. B. Portnoy, V. Kostenko, D. Lefort, S. Stoimenov, S. Judit, M. Repin, G. Rouviere, Y. Khronusova, B. Kanna, F. Henriot, B. Goloshchekin, Giusepe Mancia, O. Karpenko, N. Winer, H. M. Kwon, L. Ruffini, J. Munoz, F. Lacoin, A. Matei, I. Kraiz, F. Pont, E. Nabedian, P. Ferenc, J. Wayne, A. Queguiner, E. Zídková, D. Zimmermann

Publikováno v: The Journal of Clinical Hypertension. 14:206-215

This 8-week, randomized, double-blind, controlled study compared efficacy and tolerability of telmisartan/amlodipine (T/A) single-pill combination (SPC) vs the respective monotherapies in 858 patients with severe hypertension (systolic/diastolic bloo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::890b0b5f78d34b7908d26a214474eb2c
https://doi.org/10.1111/j.1751-7176.2012.00595.x

Impact of antihypertensive combination and monotreatments on blood pressure variability: assessment by old and new indices. Data from a large ambulatory blood pressure monitoring database

Autor: Helmut Schumacher, Ludwin Ley, Gianfranco Parati, Eamon Dolan

Publikováno v: Journal of hypertension. 32(6)

Objectives: High 24-h ambulatory blood pressure (ABP) variability is associated with poor cardiovascular outcomes. We analysed a large ABP monitoring database containing data from hypertensive patients treated with telmisartan/amlodipine combination

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba6229db3d3efaec53e981d013330a0f
https://pubmed.ncbi.nlm.nih.gov/24781510

Single-pill combination of telmisartan/amlodipine in patients with severe hypertension: results from the TEAMSTA severe HTN study

Autor: Joel M, Neutel, Giusepe, Mancia, Henry R, Black, Bjorn, Dahlöf, Holly, Defeo, Ludwin, Ley, Richard, Vinisko, B, Zehnder

Publikováno v: J Clin Hypertens (Greenwich)

J Clin Hypertens (Greenwich). 2012;14:206–215. ©2012 Wiley Periodicals, Inc. This 8‐week, randomized, double‐blind, controlled study compared efficacy and tolerability of telmisartan/amlodipine (T/A) single‐pill combination (SPC) vs the resp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1636ff02042bc5d4c1f03d92b86407d8
https://pubmed.ncbi.nlm.nih.gov/22458741